精神神经生物学研究与精神分裂症的个性化治疗
Psychoneurobiology Research and Personalized Treatment of Schizophrenia.
作者信息
Sumiyoshi Tomiki
机构信息
Department of Preventive Intervention for Psychiatric Disorders, National Institute of Mental Health, National Center of Neurology and Psychiatry, 4-1-1-Ogawahigashi-cho, Kodaira, Tokyo 187-8551, Japan.
出版信息
J Pers Med. 2021 Dec 7;11(12):1319. doi: 10.3390/jpm11121319.
Abstract
Psychoneurobiological approaches have been used to develop effective treatments for unmet needs in schizophrenia, e [...].
摘要
心理神经生物学方法已被用于开发针对精神分裂症未满足需求的有效治疗方法，例如……
相似文献
1
Psychoneurobiology Research and Personalized Treatment of Schizophrenia.精神神经生物学研究与精神分裂症的个性化治疗
J Pers Med. 2021 Dec 7;11(12):1319. doi: 10.3390/jpm11121319.
2
Ten-Year Quality-of-Life Outcomes of Patients with Schizophrenia and Schizoaffective Disorders: The Relationship with Unmet Needs for Care.精神分裂症和分裂情感性障碍患者的十年生活质量结果：与未满足的护理需求的关系。
Clin Schizophr Relat Psychoses. 2015 Fall;9(3):125-34A. doi: 10.3371/CSRP.RIGR.030813. Epub 2013 Mar 14.
3
Association between Unmet Needs and Clinical Status in Patients with First Episode of Schizophrenia in Chile.智利首发精神分裂症患者未满足的需求与临床状况之间的关联
Front Psychiatry. 2015 Apr 21;6:57. doi: 10.3389/fpsyt.2015.00057. eCollection 2015.
4
Unmet needs in patients with first-episode schizophrenia: a longitudinal perspective.首发精神分裂症患者的未满足需求：纵向观察。
Psychol Med. 2012 Jul;42(7):1461-73. doi: 10.1017/S0033291711002406. Epub 2011 Nov 21.
5
Dopamine, Cognitive Impairments and Second-Generation Antipsychotics: From Mechanistic Advances to More Personalized Treatments.多巴胺、认知障碍与第二代抗精神病药物：从机制进展到更个性化的治疗
Pharmaceuticals (Basel). 2020 Nov 5;13(11):365. doi: 10.3390/ph13110365.
6
The mediating role of self-stigma and unmet needs on the recovery of people with schizophrenia living in the community.自我污名化和未满足需求对社区精神分裂症患者康复的中介作用。
Qual Life Res. 2014 Nov;23(9):2559-68. doi: 10.1007/s11136-014-0695-7. Epub 2014 Apr 23.
7
The care needs of elderly patients with schizophrenia spectrum disorders.老年精神分裂症谱系障碍患者的护理需求。
Am J Geriatr Psychiatry. 2013 Feb;21(2):129-37. doi: 10.1016/j.jagp.2012.10.008. Epub 2013 Jan 22.
8
Unmet Needs in Schizophrenia.精神分裂症未满足的需求。
CNS Neurol Disord Drug Targets. 2017;16(8):870-884. doi: 10.2174/1871527316666170803143927.
9
Drug repurposing and emerging adjunctive treatments for schizophrenia.精神分裂症的药物重新利用及新兴辅助治疗方法
Expert Opin Pharmacother. 2015 May;16(7):1049-67. doi: 10.1517/14656566.2015.1032248. Epub 2015 Apr 12.
10
The relationship of needs and quality of life in persons with schizophrenia living in the community. A Nordic multi-center study.社区中精神分裂症患者的需求与生活质量的关系。一项北欧多中心研究。
Nord J Psychiatry. 2003;57(1):5-11. doi: 10.1080/08039480310000194.
本文引用的文献
1
Study Protocol: The Evaluation Study for Social Cognition Measures in Japan (ESCoM).研究方案：日本社会认知测量评估研究（ESCoM）
J Pers Med. 2021 Jul 16;11(7):667. doi: 10.3390/jpm11070667.
2
Schizophrenia-Like Behavioral Impairments in Mice with Suppressed Expression of Piccolo in the Medial Prefrontal Cortex.内侧前额叶皮层中 piccolo 表达受抑制的小鼠出现类似精神分裂症的行为障碍。
J Pers Med. 2021 Jun 26;11(7):607. doi: 10.3390/jpm11070607.
3
New Insights Regarding Diagnosis and Medication for Schizophrenia Based on Neuronal Synapse-Microglia Interaction.基于神经元突触-小胶质细胞相互作用的精神分裂症诊断与用药新见解
J Pers Med. 2021 May 3;11(5):371. doi: 10.3390/jpm11050371.
4
Efficacy and Safety of Multi-Session Transcranial Direct Current Stimulation on Social Cognition in Schizophrenia: A Study Protocol for an Open-Label, Single-Arm Trial.多疗程经颅直流电刺激对精神分裂症社会认知的疗效和安全性：一项开放标签单臂试验的研究方案
J Pers Med. 2021 Apr 19;11(4):317. doi: 10.3390/jpm11040317.
5
Prolonged P300 Latency in Antipsychotic-Free Subjects with At-Risk Mental States Who Later Developed Schizophrenia.有精神病风险且后来发展为精神分裂症的未服用抗精神病药物受试者的P300潜伏期延长。
J Pers Med. 2021 Apr 21;11(5):327. doi: 10.3390/jpm11050327.
6
Evaluation of Social Cognition Measures for Japanese Patients with Schizophrenia Using an Expert Panel and Modified Delphi Method.使用专家小组和改良德尔菲法对日本精神分裂症患者的社会认知测量方法进行评估。
J Pers Med. 2021 Apr 6;11(4):275. doi: 10.3390/jpm11040275.
7
Genetic Polymorphisms of Receptors and Antipsychotic-Induced Metabolic Dysfunction in Patients with Schizophrenia.精神分裂症患者受体的基因多态性与抗精神病药物所致代谢功能障碍
J Pers Med. 2021 Mar 5;11(3):181. doi: 10.3390/jpm11030181.
8
Cannabis Use Induces Distinctive Proteomic Alterations in Olfactory Neuroepithelial Cells of Schizophrenia Patients.大麻使用在精神分裂症患者的嗅神经上皮细胞中诱导出独特的蛋白质组学改变。
J Pers Med. 2021 Feb 25;11(3):160. doi: 10.3390/jpm11030160.
9
Increased Heschl's Gyrus Duplication in Schizophrenia Spectrum Disorders: A Cross-Sectional MRI Study.精神分裂症谱系障碍中颞横回重复增加：一项横断面MRI研究。
J Pers Med. 2021 Jan 12;11(1):40. doi: 10.3390/jpm11010040.
10
Cognitive Insight in First-Episode Psychosis: Changes during Metacognitive Training.首发精神病中的认知洞察力：元认知训练期间的变化
J Pers Med. 2020 Nov 27;10(4):253. doi: 10.3390/jpm10040253.
Zotero 插件